MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for use in the discovery, development, and manufacture of drug therapies, as well as in laboratories; and specialty chemicals for use in displays, computer chips, surfaces, Integrated circuits, microelectronic systems, anti-reflection coatings, and cosmetics. It has alliances with Pfizer Inc., Bristol-Myers Squibb Company, Intrexon Corporation, Avillion LLP., F-star Delta Ltd, SFJ Pharmaceuticals Group, Alibaba Health, Checkmate Pharmaceuticals, Solvias, and Leap Therapeutics, Inc., as well as a collaboration with Daiichi Sankyo Company, Limited. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone49-61-517-20
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$17.52 billion
Profitability
Miscellaneous
Employees54,009
Next Earnings DateN/A
OptionableNot Optionable
Merck KGaA (OTCMKTS:MKGAF) Frequently Asked Questions
What is Merck KGaA's stock symbol?
Merck KGaA trades on the OTCMKTS under the ticker symbol "MKGAF."
How were Merck KGaA's earnings last quarter?
Merck KGaA (OTCMKTS:MKGAF) announced its quarterly earnings data on Thursday, March, 7th. The company reported $1.39 earnings per share (EPS) for the quarter. The company earned $4.44 billion during the quarter. View Merck KGaA's Earnings History.
Has Merck KGaA been receiving favorable news coverage?
Press coverage about MKGAF stock has trended somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Merck KGaA earned a news impact score of 0.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 7.0 out of 10, meaning that recent press coverage is likely to have an effect on the company's share price in the near future.
Who are some of Merck KGaA's key competitors?
Some companies that are related to Merck KGaA include Advanced Accelerator Application (AAAP), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aralez Pharmaceuticals (ARLZ), ARMO Biosciences (ARMO), Bohai Pharmaceuticals Group (BOPH), Cardiome Pharma (CRME), Concordia International (CXRXD), Concordia International (CXRX), Depomed (DEPO), Egalet (EGLT), Eleven Biotherapeutics (EBIO), Epirus Biopharmaceuticals (EPRSQ), ERBA Diagnostics (ERBA) and FutureWorld (FWDG).
What other stocks do shareholders of Merck KGaA own?
Who are Merck KGaA's key executives?
Merck KGaA's management team includes the folowing people:
- Dr. Stefan Oschmann, Chairman of Exec. Board & CEO (Age 62)
- Dr. Marcus Kuhnert, CFO & Member of Exec. Board (Age 51)
- Dr. Kai Beckmann, CEO of Performance Materials & Member of the Exec. Board (Age 54)
- Dr. Udit Batra, CEO of Life Science & Member of Exec. Board (Age 48)
- Ms. Belén Garijo López M.D., CEO of Healthcare & Member of the Exec. Board (Age 59)
How do I buy shares of Merck KGaA?
Shares of MKGAF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Merck KGaA's stock price today?
One share of MKGAF stock can currently be purchased for approximately $99.9550.
What is Merck KGaA's official website?
How can I contact Merck KGaA?
Merck KGaA's mailing address is Frankfurter Strasse 250, Darmstadt 2M, 64293. The company can be reached via phone at 49-61-517-20 or via email at [email protected]
MarketBeat Community Rating for Merck KGaA (OTCMKTS MKGAF)
MarketBeat's community ratings are surveys of what our community members think about Merck KGaA and other stocks. Vote "Outperform" if you believe MKGAF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MKGAF will underperform the S&P 500 over the long term. You may vote once every thirty days.
